References
- New Technical Report Series on the Control of Leishmaniasis. World Health Organization (Available from: http://www.who.int/neglected_diseases/integrated_media/integrated_media_2010_leishmaniasis/en/).
- Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol 2010;7:699–705.
- Croft SL, Yardley V, Kendrick H. Drug sensitivity of Leishmania species: some unresolved problems. Trans R Soc Trop Med Hyg 2002;96:S127–S129.
- Croft SL. Monitoring drug resistance in leishmaniasis. Trop Med Int Health 2001;6:899–905.
- Ashutosh, Sundar S, Goyal N. Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 2007;56:143–153.
- Navin TR, Arana BA, Arana FE, Berman JD, Chajón JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:528–534.
- Bogdan C, Röllinghoff M. How do protozoan parasites survive inside macrophages? Parasitol 1999;15:22–28.
- Mauël J, Ransijn A. Leishmaniaspp.: mechanisms of toxicity of nitrogen oxidation products. Exp Parasitol 1997;87:98–111.
- Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818–2825.
- Souza AS, Giudice A, Pereira JM, Guimarães LH, de Jesus AR, de Moura TR, . Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis 2010;10:209.
- Van Assche T, Deschacht M, da Luz RA, Maes L, Cos P. Leishmania-macrophage interactions: insights into the redox biology. Free Radic Biol Med 2011;51:337–351.
- Sarkar A, Saha P, Mandal G, Mukhopadhyay D, Roy S, Singh SK, . Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis. Cytometry A 2011;79:35–45.
- Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 2010;65:496–507.
- Saha P, Sen R, Hariharan C, Kumar D, Das P, Chatterjee M, . Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res 2009;43:1101–1110.
- Sarkar A, Mandal G, Singh N, Sundar S, Chatterjee M. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. Exp Parasitol 2009;122:299–305.
- Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47:469–474.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
- Guirges SY. Natural and experimental re-infection of man with Oriental sore. Ann Trop Med Parasitol 1971; 65:197–205.
- de Oliveira JP, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, . Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis 2007;6:5.
- Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E, . Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. J Eur Acad Dermatol Venereol 2009;23:1189–1192.
- Murray HW. Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 2004;71:787–794.
- More B, Bhatt H, Kukreja V, Ainapure SS. Miltefosine: great expectations against visceral leishmaniasis. J Postgrad Med 2003;49:101–103.
- Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2007; 51:1425–1430.
- Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, . Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis. BMC Infect Dis 2007;7:7.
- Mauël J, Corradin SB, Buchmüller Rouiller Y. Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Res Immunol 1991;142:577–580.
- Mandal G, Sarkar A, Saha P, Singh N, Sundar S, Chatterjee M, . Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. Indian J Biochem Biophys 2009;46:86–92.
- Mehta A, Shaha C. Mechanism of metalloid-induced death in Leishmania spp.: role of iron, reactive oxygen species, Ca2 +, and glutathione. Free Radic Biol Med 2006;40:1857–1868.
- Wan CP, Myung E, Lau BH. An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes. J Immunol Methods 1993;159:131–138.
- Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001;89:224–236.
- Mandal G, Wyllie S, Singh N, Sundar S, Fairlamb AH, Chatterjee M, . Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 2007;134:1679–1687.
- Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A. Trypanothione: a novel bis(glutathionyl)-spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985;227:1485–1487.
- Fairlamb AH, Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 1992;46:695–729.
- Müller S, Liebau E, Walter RD, Krauth-Siegel RL. Thiol-based redox metabolism of protozoan parasites. Trends Parasitol 2003;19:320–328.
- Reckenfelderbäumer N, Krauth-Siegel RL. Catalytic properties, thiol pK value, and redox potential of Trypanosoma brucei tryparedoxin. J Biol Chem 2002;277:17548–17555.
- Halliwell B. Vitamin C and genomic stability. Mutat Res 2001;475:29–35.
- Flohé L, Hecht HJ, Steinert P. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 1999;27:966–984.
- Wyllie S, Cunningham ML, Fairlamb AH. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 2004;279: 39925–39932.
- Mukhopadhyay R, Dey S, Xu N, Gage D, Lightbody J, Ouellette M, . Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc Natl Acad Sci USA 1996;93:10383–10387.
- Wyllie S, Mandal G, Singh N, Sundar S, Fairlamb AH, Chatterjee M, . Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Mol Biochem Parasitol 2010;173:162–164.
- Dey R, Datta SC. Leishmanial glycosomes contain superoxide dismutase. Biochem J 1994;301:317–319.
- Sundar S, Chatterjee M. Visceral Leishmaniasis: current therapeutic modalities. Indian J Med Res 2006;123: 345–352.
- Mookerjee Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, . Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmaniadonovani infected macrophages. Antimicrob Agents Chemother 2006;50:1788–1797.
- Krauth-Siegel RL, Meiering SK, Schmidt H. The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania. Biol Chem 2003;384:539–549.
- Paramchuk WJ, Ismail SO, Bhatia A, Gedamu L. Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: role in pathogenesis. Mol Biochem Parasitol 1997;90:203–221.